DCGI Apporval For Corbevax: The right to fight against corona is right, now the children have been approved for this vaccine

DCGI Apporval For Corbevax – Covid-19 Vaccine Corbevax is delivered to the body through the muscles and requires two doses of this vaccine in 28 days. The vaccine is stored at temperatures of 2 to 8 ° C.

DCGI Apporves Emergency Use Of Corbevax For Children

India has now got another new weapon for its ongoing war against Corona. In order to expedite the vaccination of children, the Drugs Controller General of India (DCGI) has given the final approval for the Corona Vaccine to the Corona Vaccine of Biological E Limited. In the country, this vaccine ( Covid-19 Vaccine ) is given to children aged 12 to 18 years.

vaccine manufacturer Biological E Ltd for children aged 12 to 18 says DCGI has approved a local vaccine for emergency use of children between the ages of 12 and 18. It is noteworthy here that the Drugs Controller General of India has already approved the Emergency Use of Carbavax for Adults. Corbevax is India’s first locally developed RBD protein sub-component vaccine against corona.

Take two doses in 28 days

Srinivas Kosaraju, head of quality and control affairs at the company, said in September last year that the company had approved a II-III clinical trial of carbavax on children aged five to 18 years. The carbavax vaccine is delivered to the body through the muscles and must be taken in two doses in 28 days. 

DCGI Apporval For Corbevax: The right to fight against corona is right, now the children have been approved for this vaccine
DCGI Apporval For Corbevax: The right to fight against corona is right, now the children have been approved for this vaccine

Just last week, the Central Drug Regulatory Subject Expert Panel (SEC) recommended the approval of the Biologic-E Corona Vaccine Carbeaux for emergency use for children aged 12 to 18 with certain conditions. It was then sent to the Drug Controller General of India (DCGI) for final approval.